S.B. No. 2308
Sign in to read the full text
The document summary and details above are public. The full text is available to signed-in accounts.
Bill text
Enrolled
SB 2308 — Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
SB 2308 (Enrolled)
Enrolled text of SB 2308.